Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May;197(5):3166-3183.
doi: 10.1007/s12010-024-05159-z. Epub 2025 Jan 20.

Circular RNA ATP9A Stimulates Non-small Cell Lung Cancer Progression via MicroRNA-582-3p/Ribosomal Protein Large P0 Axis and Activating Phosphatidylinositol 3-Kinase/Protein Kinase B Signaling Pathway

Affiliations

Circular RNA ATP9A Stimulates Non-small Cell Lung Cancer Progression via MicroRNA-582-3p/Ribosomal Protein Large P0 Axis and Activating Phosphatidylinositol 3-Kinase/Protein Kinase B Signaling Pathway

Dingxue Wang et al. Appl Biochem Biotechnol. 2025 May.

Abstract

Circular RNAs (circRNAs), along with their pathogenic property in non-small cell lung cancer (NSCLC), require comprehensive analyses and explanations. The study is established with the purpose to elucidate the potential molecular mechanism of circATP9A in NSCLC. CircATP9A and microRNA (miR)-582-3p were evaluated by real-time quantitative polymerase chain reaction, and ribosomal protein large P0 (RPLP0), cleaved caspase-3, cleaved Ki-67, epithelial-to-mesenchymal transition (EMT)-associated proteins (N-cadherin and E-cadherin), and core proteins of the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT) pathway were by Western blot. The processes of proliferation, apoptosis, migration, and invasion were measured by cell counting kit-8, 5-ethynyl-2'deoxyuridine, flow cytometry, and Transwell. Gene interaction was verified by RNA immunoprecipitation and dual luciferase reporter assay. CircATP9A and RPLP0 were abnormally highly expressed in both NSCLC tissues and cell lines, while miR-582-3p was abnormally low. Knockdown of circATP9A reduced NSCLC proliferation, invasion migration, and EMT and promoted apoptosis. This was further validated in nude mouse xenograft experiments. The inhibitory effect of knockdown of circATP9A on NSCLC was reversed by knockdown of miR-582-3p. In addition, the promoting effect of overexpression of circATP9A on NSCLC was reversed by knockdown of RPLP0. Mechanistically, circATP9A acted as a competitive endogenous RNA, sequestering miR-582-3p away from its target, which in turn modulated the expression of RPLP0. CircATP9A activated the miR-582-3p/RPLP0 axis by regulating the PI3K/Akt pathway in NSCLC cells. CircATP9A stimulates NSCLC progression via miR-582-3p/RPLP0 axis and PI3K/AKT cascade activation.

Keywords: NSCLC circATP9A; miR-582-3p; RPLP0.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethical Approval: The present study was approved by the Ethics Committee of The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine. All procedures were performed in accordance with the ethical standards of the Institutional Review Board and The Declaration of Helsinki, and its later amendments or comparable ethical standards. And all procedures complied with the National Institutes of Health Guide for the Use of Laboratory Animals. Consent to Participate: Written informed consent was provided by all patients prior to the study start. Consent for Publication: Written informed consent for publication was obtained from all participants. Competing Interests: The authors declare no competing interests.

Similar articles

Cited by

References

    1. Reck, M., et al. (2014). Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis treatment and follow-up. Annals Oncology, 25(Suppl 3), iii27-39. - DOI
    1. Thai, A. A., et al. (2021). Lung cancer. Lancet, 398(10299), 535–554. - PubMed - DOI
    1. Willers, H., et al. (2013). Basic mechanisms of therapeutic resistance to radiation and chemotherapy in lung cancer. Cancer Journal, 19(3), 200–207. - PubMed - DOI
    1. Verdecchia, A., et al. (2007). Recent cancer survival in Europe: A 2000–02 period analysis of Eurocare-4 data. Lancet Oncology, 8(9), 784–796. - PubMed - DOI
    1. Li, C., et al. (2019). Circular RNAs: Pivotal molecular regulators and novel diagnostic and prognostic biomarkers in non-small cell lung cancer. Journal Cancer Research Clinics Oncology, 145(12), 2875–2889. - DOI

MeSH terms

LinkOut - more resources